急诊科床旁超声对危重非创伤患者诊疗流程与结局的影响
该回顾性队列研究纳入两家学术急诊科收治的成人非创伤危重患者(休克指数>0.6),比较无床旁超声、关键干预前床旁超声、关键干预后床旁超声三组的住院死亡率。共5441例纳入分析,三组死亡率分别为22%、29%、26%(p<0.001)。多变量logistic回归显示,干预前使用床旁超声与死亡校正OR 1.41(95%CI 1.12-1.76)相关。敏感性分析显示干预前超声组较无超声组绝对死亡率增加+0.05(95%CI 0.02-0.09)。作者认为干预前床旁超声似乎与诊疗延迟和住院死亡率增加相关,需进一步探索。
要点
- 在休克指数>0.6的成人非创伤危重患者中,关键干预前使用床旁超声与死亡校正OR 1.41(95%CI 1.12-1.76)相关。
- 三组住院死亡率分别为无超声22%、干预前超声29%、干预后超声26%(p<0.001)。
- 敏感性分析显示干预前超声组较无超声组绝对死亡率增加+0.05(95%CI 0.02-0.09)。
- 作者认为干预前床旁超声似乎与诊疗延迟及住院死亡率增加相关,需进一步探索。
适用人群与场景
- 成人(>18岁)非创伤急诊患者,伴血流动力学不稳定,休克指数(心率/收缩压)>0.6。
- 纳入2013年11月1日至2016年10月31日期间就诊于两家学术急诊科、收入重症监护室或在急诊科死亡的患者。
诊断标准与关键阈值
- 血流动力学不稳定定义为休克指数(心率/收缩压)>0.6。
研究设计与关键结果
- 研究设计为回顾性队列研究,纳入两家学术急诊科收治的危重非创伤患者,共7734例符合条件,排除2293例,最终分析5441例:无床旁超声组4165例、关键干预前床旁超声组614例、关键干预后床旁超声组662例。
- 关键干预定义为液体推注或启动血管活性药物。
- 主要终点为住院死亡率,三组分别为22%、29%、26%(p<0.001)。
- 多变量logistic回归显示,与无床旁超声相比,干预前使用床旁超声与死亡的校正OR为1.41(95%CI 1.12-1.76)。
- 敏感性分析(倾向性评分匹配、逆概率加权回归调整及多重插补)显示,干预前超声组较无超声组绝对死亡率增加+0.05(95%CI 0.02-0.09)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在血流动力学不稳定的非创伤危重患者中,干预前使用床旁超声似乎与诊疗延迟及住院死亡率增加相关。
- 作者认为,进一步探索床旁超声在急诊科的影响似乎是必要的。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Outcomes data on point-of-care ultrasound (POCUS) in critically ill patients are lacking. This study examines the association between POCUS in the emergency department and outcomes in critically ill patients.
DESIGN: Retrospective cohort study of critically ill emergency department patients in two academic emergency departments. All emergency department patients admitted to the intensive care unit or that die in the emergency department were entered prospectively into a registry.
SETTING: Two academic emergency departments.
PATIENTS: All adult (> 18 years old) non-trauma patients with hemodynamic instability [shock index (heart rate/systolic blood pressure) > 0.6] between November 1, 2013-October 31, 2016, were included.
INTERVENTIONS: Cohorts were assigned as follows: no POCUS (cohort 1), POCUS prior to a key intervention (cohort 2), and POCUS after a key intervention (cohort 3). A key intervention was either a fluid bolus or vasoactive drug initiation.
MEASUREMENTS AND MAIN RESULTS: Multivariable logistic regression was used to evaluate the association between POCUS use and the primary outcome of in-hospital mortality. We conducted several sensitivity analyses including propensity score matching and inverse-probability-weighted regression-adjustment along with multiple imputation to account for non-random assignment of POCUS as well as bias due to missing data. Of the 7,734 eligible patients, 2,293 patients were excluded. The remaining 5,441 patients were included in the analysis: 4165 in Cohort 1, 614 in Cohort 2, and 662 in Cohort 3. Mortality was 22%, 29%, and 26%, respectively (p < 0.001). POCUS prior to an intervention was associated with an adjusted odds ratio for death of 1.41 (95% CI, 1.12-1.76) compared to no POCUS. The sensitivity analyses showed an absolute increased mortality of +0.05 (95% CI, 0.02-0.09) for cohort 2 compared to 1.
CONCLUSIONS: POCUS use prior to interventions appears to be associated with care delays and increased in-hospital mortality compared to critically ill patients with no POCUS. Further explorations of the impact of POCUS in the emergency department appear warranted.
参考来源
- Mosier JM, Stolz U, Milligan R, et al. Impact of Point-of-Care Ultrasound in the Emergency Department on Care Processes and Outcomes in Critically Ill Nontraumatic Patients. Crit Care Explor. 2019. PMID: 32166263. doi:10.1097/CCE.0000000000000019
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。